SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-006290
Filing Date
2015-08-18
Accepted
2015-08-18 08:01:02
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0615_yewbiopharm.htm 10-Q 794637
2 CERTIFICATION f10q0615ex31i_yewbiopharm.htm EX-31.1 8026
3 CERTIFICATION f10q0615ex31ii_yewbiopharm.htm EX-31.2 7851
4 CERTIFICATION f10q0615ex32_yewbiopharm.htm EX-32 3658
  Complete submission text file 0001213900-15-006290.txt   4936202

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20150630.xml EX-101.INS 1198886
6 XBRL SCHEMA FILE yewb-20150630.xsd EX-101.SCH 50478
7 XBRL CALCULATION FILE yewb-20150630_cal.xml EX-101.CAL 37687
8 XBRL DEFINITION FILE yewb-20150630_def.xml EX-101.DEF 97775
9 XBRL LABEL FILE yewb-20150630_lab.xml EX-101.LAB 386198
10 XBRL PRESENTATION FILE yewb-20150630_pre.xml EX-101.PRE 239080
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 151060174
SIC: 0100 Agricultural Production-Crops